Yes, Levophed is a vasopressor. It is the brand name for norepinephrine, and the FDA labels it specifically as a “potent vasopressor” and “pressor agent.” In fact, norepinephrine is considered the gold standard vasopressor in critical care medicine, recommended as the first-line choice for treating septic shock by major international guidelines.
What Levophed Does in the Body
Levophed works by mimicking norepinephrine, a chemical your body naturally releases during the “fight or flight” response. It targets two types of receptors on cells throughout your body, each producing a different effect.
Its strongest action is on alpha receptors in blood vessel walls. When Levophed activates these receptors, blood vessels constrict, which raises blood pressure. This is the core vasopressor effect and the primary reason the drug is used. It also activates beta-1 receptors in the heart, which increases the force of each heartbeat and helps push more blood through the circulatory system. A secondary effect is dilation of the coronary arteries, improving blood flow to the heart muscle itself.
The combination of tighter blood vessels and a stronger heartbeat makes Levophed especially effective at rescuing dangerously low blood pressure. Unlike some other vasopressors that raise heart rate significantly or work through indirect mechanisms, norepinephrine provides a relatively predictable and controllable increase in blood pressure.
When Levophed Is Used
Levophed is approved for blood pressure control in acute hypotensive states, meaning situations where blood pressure has dropped suddenly and dangerously. The most common scenario is septic shock, where a severe infection causes blood vessels to relax and blood pressure to plummet. The 2021 Surviving Sepsis Campaign guidelines issued a strong recommendation for norepinephrine as the first-line vasopressor over alternatives like dopamine, vasopressin, and epinephrine.
Beyond septic shock, Levophed is used during cardiac arrest, after certain surgeries, during severe allergic reactions to drugs or blood transfusions, and in cases of profound low blood pressure from spinal anesthesia. In all of these situations, the goal is the same: restore enough blood pressure to keep vital organs perfused with oxygen.
How It Is Given
Levophed is administered only through an intravenous drip in a hospital setting, typically in an intensive care unit. It is never taken as a pill or given as a single injection. The drug is delivered as a continuous infusion, meaning it flows steadily into a vein through an IV pump that medical staff can adjust in real time.
Dosing typically starts very low and is increased in small increments every couple of minutes until blood pressure reaches a target, usually a mean arterial pressure of 65 to 70 mmHg. This careful titration allows the care team to find the lowest effective dose, which matters because higher doses carry greater risk of side effects. The infusion can be dialed up or down as a patient’s condition changes, sometimes over the course of hours or days.
Risks and Side Effects
Because Levophed constricts blood vessels so powerfully, the most serious risk involves what happens if the drug leaks out of the vein and into surrounding tissue. This is called extravasation, and it can cause the tissue around the IV site to lose blood flow, turning cold, pale, and hard. Without prompt treatment, the affected skin and tissue can die. Medical teams monitor IV sites closely for this reason, and if a leak is caught early, a medication that blocks Levophed’s vessel-constricting effect can be injected into the area to restore blood flow.
Other potential effects stem from the drug doing its job too well. Excessively high blood pressure is a concern, particularly in patients taking certain medications. People who have recently used MAO inhibitors (a class of drugs sometimes prescribed for depression or Parkinson’s disease) or tricyclic antidepressants face a risk of severe, prolonged blood pressure spikes if given Levophed. In the ICU setting, the medical team reviews all current medications before starting the infusion.
How It Compares to Other Vasopressors
Several drugs can raise blood pressure, but they differ in how they do it and what side effects they carry. Dopamine, once a popular first choice, fell out of favor after studies showed it caused more irregular heart rhythms than norepinephrine. Vasopressin works through an entirely different pathway (it acts on receptors in blood vessels unrelated to adrenaline) and is often added as a second agent when norepinephrine alone is not enough. Epinephrine is a stronger heart stimulant but tends to cause more metabolic side effects.
Norepinephrine earned its first-line status because it reliably raises blood pressure with a relatively favorable side effect profile compared to these alternatives. The strong recommendation from the Surviving Sepsis Campaign reflects consistent evidence across multiple studies that outcomes are as good or better with norepinephrine than with other vasopressors, and that the balance of benefits to risks tips clearly in its favor for most patients in shock.